These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2906104)

  • 1. [Adrenergic beta receptor blockaders with intrinsic sympathomimetic activity in the treatment of arterial hypertension].
    Pyda M; Grajek S
    Kardiol Pol; 1988; 31(4):261-70. PubMed ID: 2906104
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
    v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
    J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adrenergic beta receptor blockaders in the treatment of arterial hypertension].
    Chodakowska J
    Pol Tyg Lek; 1982 Nov; 37(44):1331-4. PubMed ID: 6131408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
    Halawa B
    Pol Tyg Lek; 1987 Feb; 42(6):153-5. PubMed ID: 3037504
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihypertensive and hemodynamic effects of beta-receptor blockaders with various action spectra].
    Lohmöller G; Lydtin H; Frohlich ED
    Adv Clin Pharmacol; 1976; 11():94-8. PubMed ID: 25572
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of hypertension using various beta receptor blockaders (timolol, alprenolol, prindolol].
    Heinze A; Wessels F; Losse H
    Verh Dtsch Ges Kreislaufforsch; 1975; 41():380-2. PubMed ID: 7887
    [No Abstract]   [Full Text] [Related]  

  • 8. [Centra, peripheral, and volumetric hemodynamic changes in the treatment of essential hypertension with calcium antagonists and beta blockaders].
    Mattioli G; Ricci S; Teglio V
    Minerva Cardioangiol; 1980 May; 28(5):295-302. PubMed ID: 6111047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive effect of beta-blockaders].
    Liebau H; Jarosch von Schweder W
    Verh Dtsch Ges Inn Med; 1974; 80():268-72. PubMed ID: 4156114
    [No Abstract]   [Full Text] [Related]  

  • 10. Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension.
    Schirger A; Sheps SG; Spiekerman RE; Harman TR; Kleven MK
    Mayo Clin Proc; 1983 May; 58(5):315-8. PubMed ID: 6843182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity.
    Simon AC; Levenson J; Pithois-Merli I
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):45S-49S. PubMed ID: 2894224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].
    Erina EV; Charyev KhE; Lediashova GA; Smolenskiĭ AV
    Ter Arkh; 1983; 55(9):43-8. PubMed ID: 6314576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
    Mattioli G; Ricci S; Menozzi A; Teglio V
    Minerva Cardioangiol; 1982 Mar; 30(3):81-8. PubMed ID: 6123962
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of partial agonist activity in man and its therapeutic relevance.
    Carruthers SG
    Arq Bras Cardiol; 1984 Mar; 42(3):223-5. PubMed ID: 6148056
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of arterial hypertension using beta-blockaders].
    Cottier P
    Ther Umsch; 1974 Nov; 31(11):772-8. PubMed ID: 4154519
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemodynamic effect of beta receptor blockaders in arterial hypertension].
    Anlauf M; Bock KD
    Verh Dtsch Ges Inn Med; 1974; 80():189-99. PubMed ID: 4156112
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
    Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of treatment with pindolol (Visken) on hemodynamics in patients with primary hypertension].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1986; 29(4):285-91. PubMed ID: 3537436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.